Safety Profile and Precautions for 25mg Dose

Weight 45 kg or more: 40 mg PO 3 times daily.Weight 21 to 44 kg: 20 mg PO 3 times daily.Weight 20 kg or less: 10 mg PO 3 times daily. Guidelines recommend 1 mg/kg/dose PO every 8 hours.

• Sildenafil's molecular weight is 666.7 g/mol for the free base.
• The citrate salt formulation improves solubility and absorption.
• Taking it after a large, fatty dinner may mean waiting 2 hours for full effect.
• It is not recommended for men with severe hypotension (BP <90/50).
• Can be used by men with stable coronary artery disease on appropriate therapy.
• The medication's patent expiration led to a substantial price decrease.
• Some men may experience dyspepsia (indigestion) as a side effect.
• It is important to rule out hypogonadism (low testosterone) as a cause of ED.
• The pill does not work if the nerves or blood supply to the penis are severely damaged.
• Patient assistance programs may be available for brand-name Viagra.
• Honesty with your doctor about all health issues is crucial for safe use.

Guidelines recommend 1 mg/kg/dose PO every 8 hours and 0.4 mg/kg IV as a loading dose followed by a continuous infusion of 0.067 mg/kg/hour.

Membership Benefits

Decreases in blood pressure were also observed. No significant effect on the pharmacokinetic parameters of tacrolimus were observed. Tamsulosin: (Moderate) Due to the potential for symptomatic hypotension, patients should be stable on tamsulosin therapy before initiating therapy with the lowest dose of sildenafil. Tazemetostat: (Moderate) Monitor for decreased efficacy of sildenafil if coadministration with tazemetostat is necessary as concurrent use may decrease sildenafil exposure. Sildenafil is a sensitive CYP3A4 substrate and tazemetostat is a weak CYP3A4 inducer.

Pulmonary hypertension

Telmisartan; Amlodipine: (Moderate) Monitor for additive hypotension if amlodipine is administered concurrently with sildenafil, as both agents act independently to reduce blood pressure. Telotristat Ethyl: (Moderate) Monitor for decreased viagra super efficacy of sildenafil if coadministration with telotristat is necessary as concurrent use may decrease sildenafil exposure. Terazosin: (Moderate) Due to the potential for symptomatic hypotension, patients should be stable on alpha-blocker therapy before initiating therapy with the lowest dose of sildenafil. Tezacaftor; Ivacaftor: (Moderate) Increased monitoring is recommended if ivacaftor is administered concurrently with CYP2C9 substrates, such as sildenafil. Tipranavir: (Major) Sildenafil is contraindicated for use with tipranavir when used for pulmonary arterial hypertension (PAH). Nitric oxide then activates the enzyme guanylate cyclase, which results in increased levels of cGMP. Cyclic guanosine monophosphate causes smooth muscle relaxation in the corpus cavernosum thereby allowing inflow of blood; the exact mechanism by which cGMP stimulates relaxation of smooth muscles has not been determined. PDE5 is responsible for degradation of cGMP in the corpus cavernosum. Sildenafil enhances the effect of NO by inhibiting PDE5 thereby raising concentrations of cGMP in the corpus cavernosum. Sildenafil has no direct relaxant effect on isolated human corpus cavernosum and, at recommended doses, has no effect in the absence of sexual stimulation.

As reported by the manufacturer, the pharmacodynamic response to sildenafil was assessed in eight double-blind, placebo-controlled crossover studies of patients with either organic or psychogenic erectile dysfunction.

Society and culture

When given together these agents may produce an additive reduction in blood pressure. The combination of sapropterin and a phosphodiesterase (PDE5) inhibitor did not significantly reduce blood pressure when administered concomitantly in animal studies. The additive effect of these agents has not been studied in humans. Saquinavir: (Major) Sildenafil is contraindicated for use with saquinavir when used for pulmonary arterial hypertension (PAH). Coadministration of saquinavir increased the sildenafil AUC by about 3-fold in a drug interaction study.

Incidence not known

Silodosin: (Moderate) Due to the potential for symptomatic hypotension, patients should be stable on silodosin therapy before initiating therapy with the lowest dose of sildenafil. Conversely, patients already receiving an optimized dose of sildenafil should be started on the lowest dose of silodosin; increases in the alpha-blocker dose should be done in a stepwise fashion. Other variables, such as intravascular volume depletion, concurrent antihypertensive therapy, or evidence of hemodynamic instability with alpha-blocker monotherapy, may affect the safety of concomitant use of sildenafil and silodosin. Sodium Phenylbutyrate; Taurursodiol: (Moderate) Monitor for decreased efficacy of sildenafil if coadministration with taurursodiol is necessary as concurrent use may decrease sildenafil exposure. Sotorasib: (Moderate) Monitor for decreased efficacy of sildenafil if coadministration with sotorasib is necessary as concurrent use may decrease sildenafil exposure. In these studies sexual stimulation resulted in improved erections, as assessed by penile plethysmography, after sildenafil administration compared with placebo. Most studies evaluated the efficacy of sildenafil approximately 60 minutes post dose. The erectile response, as determined by penile plethysmography, generally increased with increasing sildenafil dose and plasma concentration. The time course of effect was examined in one study. The effects of sildenafil were evident for up to 4 hours, but the response was diminished compared to 2 hours.In vitro studies show that sildenafil is selective for PDE5 and its effect is more potent on PDE5 than on other known phosphodiesterases. Sildenafil can also inhibit PDE5 present in esophageal smooth muscle, lung tissue, and brain tissue.

Further information

Sildenafil is a sensitive CYP3A4 substrate; tipranavir is a strong CYP3A4 inhibitor. Trandolapril; Verapamil: (Moderate) Monitor for an increase in sildenafil-related adverse reactions if coadministration with verapamil is necessary; consider a starting dose of 25 mg of sildenafil when prescribed for erectile dysfunction. Tranylcypromine: (Moderate) Additive hypotensive effects may be seen when monoamine oxidase inhibitors (MAOIs) are combined with sildenafil. Tucatinib: (Major) Coadministration with tucatinib is not recommended in patients receiving sildenafil for pulmonary arterial hypertension (PAH). When sildenafil is used for erectile dysfunction, consider a starting dose of 25 mg for patients receiving tucatinib.

What strengths does Viagra come in?

Vemurafenib: (Moderate) Concomitant use of vemurafenib with sildenafil may increase sildenafil exposure. Sildenafil is cleared predominantly by CYP3A (major route) and CYP2C9 (minor route). Use caution and monitor patients for potential sildenafil-related side effects. Verapamil: (Moderate) Monitor for an increase in sildenafil-related adverse reactions if coadministration with verapamil is necessary; consider a starting dose of 25 mg of sildenafil when prescribed for erectile dysfunction. PDE5 inhibitors, including sildenafil, may potentiate the hypotensive effects of vericiguat. Inhibition of PDE5 in lung tissue results in relaxation of pulmonary vascular smooth muscle and subsequently pulmonary vasodilation, thereby making sildenafil an effective agent in treating pulmonary hypertension.

How is Viagra used?

Vigabatrin: (Major) Vigabatrin should not be used with phosphodiesterase inhibitors, which is associated with serious ophthalmic effects (e.g., retinopathy or glaucoma) unless the benefit of treatment clearly outweighs the risks. Vonoprazan; Amoxicillin; Clarithromycin: (Major) Coadministration of clarithromycin is not recommended in patients receiving sildenafil for pulmonary arterial hypertension (PAH). Voriconazole: (Major) Coadministration of voriconazole is not recommended in patients receiving sildenafil for pulmonary arterial hypertension (PAH). When sildenafil is used for erectile dysfunction, consider a starting dose of 25 mg for patients receiving voriconazole. Voxelotor: (Moderate) Monitor for an increase in sildenafil-related adverse reactions if coadministration with voxelotor is necessary; consider a starting dose of 25 mg of sildenafil when prescribed for erectile dysfunction.

Don’t drink alcohol after taking Viagra

Zafirlukast: (Moderate) Concomitant use of zafirlukast with sildenafil may increase sildenafil exposure. In vitro studies suggest zafirlukast inhibits CYP3A (weak) and CYP2C9 (moderate top potent). LiQrev Oral Susp: 1mL, 10mgRevatio/Sildenafil/Sildenafil Citrate Intravenous Inj Sol: 0.8mg, 1mLRevatio/Sildenafil/Sildenafil Citrate Oral Pwd F/Recon: 1mL, 10mgRevatio/Sildenafil/Sildenafil Citrate/Viagra Oral Tab: 20mg, 25mg, 50mg, 100mg 100 mg/day PO for erectile dysfunction; 240 mg/day PO or 30 mg/day IV for pulmonary arterial hypertension. 100 mg/day PO for erectile dysfunction; 240 mg/day PO or 30 mg/day IV for pulmonary weekend viagra arterial hypertension. Weight 45 kg or more: 40 mg PO 3 times daily.Weight 21 to 44 kg: 20 mg PO 3 times daily. Inhibition of PDE5 present in esophageal smooth muscle can cause a marked inhibition of esophageal motility as well as a reduction in lower esophageal sphincter (LES) tone.

These effects may be beneficial in certain motor disorders involving the esophagus such as diffuse spasm, nutcracker esophagus, and hypertensive LES.

• Sildenafil 25 mg is a cornerstone of oral pharmacotherapy for erectile dysfunction.
• Its mechanism involves enhancing the natural nitric oxide pathway.
• The tablet should be taken whole; do not crush or chew for intended effect.
• Men with pigmentary retinopathy should use alternative treatments.
• Can be used in men with Parkinson's disease, with physician guidance.
• The drug's success led to reduced stigma around seeking help for ED.
• It does not increase the risk of prostate cancer or benign prostatic hyperplasia.
• Combining with other ED treatments (like injections) can cause severe priapism.
• The psychological boost from successful treatment can improve relationship dynamics.
• It is essential to purchase from licensed, accredited pharmacies only.
• Regular reevaluation of the need for medication is part of good medical practice.

However, the reduction in LES tone can worsen the symptoms of gastroesophageal reflux disease (GERD). Sildenafil is one-tenth as potent for PDE6, an enzyme found in the retina, as it is for PDE5; this lower selectivity is thought to be the basis for abnormalities related to color vision observed with higher doses or plasma concentrations of the drug.

• The drug's action is localized to the penis; systemic effects are generally mild.
• Starting at a low dose allows assessment of individual pharmacokinetics.
• It is not a "party drug" and using it recreationally can be hazardous.
• Men with multiple myeloma or leukemia may have contraindications.
• Can be used by men who have undergone kidney transplantation, with doctor approval.
• The cost-effectiveness of generic sildenafil has increased treatment access.
• Some men may find the side effects diminish with continued use.
• It does not treat underlying vascular disease, a common cause of ED.
• Penile implants or injections are alternatives if oral therapy fails.
• The decision to use medication should be a shared one between patient and doctor.
• Regular check-ups are important to monitor for any new health developments.

The mean steady state volume of distribution (Vss) is 105 L, indicating widespread tissue distribution. Sildenafil is predominantly metabolized by hepatic cytochrome P450 (CYP) enzymes.

What is the risk associated with Viagra?

St. John's Wort, Hypericum perforatum: (Moderate) Monitor for decreased efficacy of sildenafil if coadministration with St. John's Wort is necessary as concurrent use may decrease sildenafil exposure. Sildenafil is a sensitive CYP3A substrate and St. John's Wort is a strong CYP3A inducer.

Typical dosages

Stiripentol: (Moderate) Consider a dose adjustment of sildenafil when coadministered with stiripentol. Coadministration may alter plasma concentrations of sildenafil resulting in an increased risk of adverse reactions and/or decreased efficacy. In vitro data predicts inhibition or induction of CYP3A4 by stiripentol potentially resulting in clinically significant interactions. Tacrolimus: (Moderate) Consider initiating sildenafil at a low dose (25 mg) in kidney transplant recipients receiving tacrolimus. In a study of renal transplant patients, coadministration of tacrolimus with a single 50 mg dose of sildenafil resulted in an increase in the AUC, Cmax, and half-life of sildenafil. One active metabolite with properties similar to the parent drug has been identified and is formed by N-desmethylation of sildenafil.

• 25 mg Viagra is often used for those who experience side effects at higher doses.
• Regular use of Viagra can improve erectile response over time.
• The medication works by increasing blood flow to the penis.
• Viagra should not be taken more than once per day.
• Consult your doctor if you experience visual disturbances while taking Viagra.
• Patients with heart problems should be cautious and inform their doctor.
• Viagra is not a cure but can help manage erectile dysfunction symptoms.